Big bets on AI and robotics in 2026
Use of AI is set to increase over the next 12 months:
- 76% agree they are planning to create generative AI systems for use in their business
- 81% are planning to use or increase the use of generative AI in the treatment of patients
- 77% are planning to use or increase the use of AI in the diagnosis of patients
- 78% are planning to use or increase the use of robotics to create, provide or support new healthcare services
- 79% agree that the future of healthcare is personalised services driven by greater data and tech insight
This represents a significant shift from 2024 when concern over such issues meant the focus was on bricks and mortar expansion. In fact, developing a face-to-face service dropped from 1st to 7th priority between 2024 and 2026.
Although 79% of executives express confidence in their AI risk management capabilities, confidence in managing bias and trust-related risks is growing. However, concern surrounding intellectual property (IP) protection remains consistently high since 2024.
- 74% are concerned about bias in generative AI (78% in 2024)
- 73% are concerned about trustworthiness of AI (80% in 2024)
- 79% are concerned about intellectual property protection (same as 2024)
Source: Beazley’s Digital Health and Wellness surveys undertaken in 2024 and 2026 with 600 executives from digital health and wellness businesses based in Europe, the US, Canada and Asia.
Such concerns should not be taken lightly.
Trust is essential yet fragile in virtual care services. Patients need confidence that their data is protected and systems are reliable. Clinicians must trust AI-generated inputs enough to use them in practice. Bias is equally critical, as under-represented groups in training data can face mis-triage or misdiagnosis, create clinical safety risks and expose organisations to regulatory scrutiny.